The mechanism through which nutritional deficiencies cause hair loss is primarily telogen effluvium (TE): a shedding disorder in which a disproportionate number of follicles shift prematurely from the anagen (growth) phase into the telogen (resting) phase. Two to four months after this shift, those follicles shed their hairs simultaneously, producing a noticeable increase in daily shedding. The follicles themselves are not miniaturised or permanently damaged in the way they are in androgenetic alopecia; the problem is cyclical disruption, not structural change. Acute TE typically resolves once the underlying trigger is addressed.

The two-to-four month delay between trigger and shed is clinically important: it means that blood tests done at the time of significant shedding reflect the nutritional status now, which may be different from the status that triggered the episode months earlier. A full picture requires understanding both current status and history.

Nutritional deficiencies are also worth distinguishing from androgenetic alopecia before beginning any topical protocol. The article on telogen effluvium vs androgenetic alopecia covers how to distinguish between them. A nutritionally-triggered TE that is mistaken for AGA may be treated with DHT-targeted interventions that address the wrong mechanism entirely.

Of all the nutritional factors studied in the context of hair loss, iron status has the most consistent evidence base. The relevant marker is ferritin, the storage form of iron, rather than serum iron alone. Serum iron fluctuates considerably through the day and in response to acute infection or inflammation; ferritin reflects total iron stores more reliably and is the appropriate test to request.

Research has observed an association between low ferritin levels and increased hair shedding, particularly in women. The mechanism is not fully characterised but is thought to involve iron's role in DNA synthesis and cell proliferation, processes that are particularly demanding in the matrix cells of actively growing follicles. When iron stores are depleted, the follicle may be preferentially pushed into telogen as the body prioritises iron delivery to more critical tissues.

A clinically important nuance: standard laboratory lower limits for ferritin (typically 12 to 15 µg/L in most UK labs) are set to detect frank iron deficiency anaemia, not to optimise follicle cycling. Some researchers in hair loss have proposed that higher thresholds may be relevant for hair health, and values that fall within the normal reference range may still be suboptimal for follicle function. This remains a contested area without a definitive clinical consensus, and the appropriate response to a borderline result is a conversation with a GP rather than independent supplementation.

Iron supplementation in genuinely deficient individuals is appropriate and may support recovery of the hair cycle, though the response takes months to manifest because the follicle cycle itself imposes a delay. Supplementing with iron when stores are adequate does not help hair growth and carries risks at higher doses; ferritin testing before supplementation is essential.

Vitamin D receptors are expressed in hair follicle keratinocytes, and animal studies have shown that disruption of vitamin D receptor signalling can impair hair follicle cycling. In humans, the relationship between vitamin D status and hair loss is less straightforward. Cross-sectional studies have observed lower serum 25-hydroxyvitamin D levels in groups with various forms of hair loss including TE and alopecia areata compared to controls, but cross-sectional data cannot establish that low vitamin D caused the shedding rather than correlating with another causal variable.

Vitamin D insufficiency is extremely prevalent in the UK population, particularly during the autumn and winter months when solar UVB exposure is insufficient to support synthesis. The standard UK guidance recommends that most adults consider 10 micrograms (400 IU) of vitamin D daily from October to March. For people who are deficient rather than merely insufficient, a GP may recommend higher therapeutic doses.

The evidence that vitamin D supplementation reduces hair shedding in deficient individuals is suggestive but not robustly established by randomised trial data. It is a reasonable part of a general health baseline for UK residents given the high background prevalence of insufficiency, with hair benefits as a potential secondary effect rather than a primary expectation.

B12 is required for DNA synthesis and red blood cell production, and deficiency can cause megaloblastic anaemia, which has documented associations with diffuse hair shedding. The mechanism mirrors the iron deficiency pathway: impaired cell division in the highly proliferative follicle matrix disrupts normal anagen and may trigger premature telogen entry.

B12 deficiency is more common than often recognised in certain populations. Vegans and vegetarians who do not supplement are at substantial risk because B12 is found almost exclusively in animal products. People taking metformin for type 2 diabetes are at elevated risk due to impaired B12 absorption in the gut. Older adults absorb B12 less efficiently due to reduced stomach acid and intrinsic factor production. Those with pernicious anaemia, an autoimmune condition that destroys the cells producing intrinsic factor, cannot absorb B12 from food at all regardless of dietary intake.

Serum B12 is the standard test, though it has limitations: it does not always detect functional deficiency in individuals whose cells are not utilising B12 effectively. Methylmalonic acid (MMA) and homocysteine are more sensitive functional markers of B12 status but are not routinely requested in primary care. If serum B12 is borderline and symptoms suggest deficiency, these additional markers may be worth discussing with a GP.

Zinc plays a role in DNA and RNA synthesis, cell division, and protein metabolism, all of which are relevant to the rapidly cycling cells in active hair follicles. Frank zinc deficiency, seen in conditions such as acrodermatitis enteropathica, produces overt hair loss alongside other systemic symptoms. At subdeficiency levels the evidence for an association with hair shedding is present but less conclusive than for iron or B12.

Isolated zinc deficiency is relatively uncommon in the UK outside of specific risk groups: people with inflammatory bowel disease, Crohn's disease, or malabsorption syndromes; those following strict plant-based diets without adequate legume, seed, and nut intake; people with alcohol dependency; and those on certain diuretics or medications that increase zinc excretion.

Serum zinc is the available clinical test, though it is not a particularly sensitive marker of status: zinc is tightly regulated in the blood, and serum levels may remain within the reference range despite reduced intracellular stores. Acute phase responses (infection, inflammation) lower serum zinc independently of true stores, which can complicate interpretation. As with other nutrients, supplementation in the absence of documented deficiency does not have meaningful evidence for benefit and high-dose zinc supplementation can impair copper absorption.

Thyroid dysfunction is not a nutritional deficiency, but it is clinically grouped with the systemic causes of diffuse hair loss and should be tested alongside nutritional markers when investigating unexplained shedding. Both hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid) can cause diffuse hair shedding, and the mechanism differs from AGA in the same way TE does: it is a cycle disruption rather than follicle miniaturisation.

Hypothyroidism is associated with reduced hair shaft production, altered hair texture (often coarser or drier), and in some cases loss of the outer third of the eyebrow. Hyperthyroidism can produce a more generalised shedding pattern. Both conditions are diagnosed primarily via thyroid stimulating hormone (TSH): a raised TSH suggests the pituitary is working harder to stimulate an underperforming thyroid; a suppressed TSH suggests the thyroid is overactive. T3 and T4 may be measured if TSH is abnormal.

Thyroid-related hair loss typically responds to appropriate medical treatment of the underlying thyroid condition, though response can take several months given the hair cycle's inherent delay. Subclinical hypothyroidism, where TSH is mildly elevated but T3 and T4 remain within range, has a less clearly established relationship with hair loss; the decision to treat is clinical and individual.

Hair shafts are composed primarily of keratin, a fibrous structural protein. Severe protein restriction, such as that associated with crash dieting, prolonged very low calorie diets, or restrictive eating disorders, can trigger TE. When dietary protein falls substantially, the body deprioritises non-essential protein use, and hair production is among the first allocations reduced.

For people consuming adequate overall protein (above roughly 0.8 to 1.0g per kilogram of body weight daily), additional protein supplementation is unlikely to benefit hair. The risk group is those actively restricting calories to a significant degree or following diets that dramatically limit protein-containing food groups. Rapid weight loss of any kind is itself a recognised trigger for TE, regardless of the macronutrient composition of the diet, which means very low calorie approaches carry dual risk: caloric stress and potential nutritional depletion.

Rapid weight loss is one of the most commonly reported triggers of telogen effluvium and deserves its own consideration distinct from protein intake. The mechanism involves two compounding stressors: the physiological stress of a significant caloric deficit, which the body registers as a systemic disruption and responds to by shifting follicles into telogen, and the nutritional depletion that often accompanies it. Either can trigger shedding independently; together they frequently do.

The shedding typically begins two to four months after the period of rapid loss, which means it often appears just as weight is stabilising and can therefore be misattributed. It usually self-limits once weight stabilises and nutritional stores recover, though the timeline depends on how depleted those stores became during the loss phase.

Several specific contexts are worth noting. Postpartum shedding involves a related but distinct mechanism, hormonal withdrawal after childbirth rather than caloric restriction, and is covered in its own dedicated detail in the article on postpartum hair loss.

If diffuse or unexplained hair shedding has developed without a clear patterned AGA presentation, the following panel of blood tests covers the most clinically relevant systemic causes. All are available through NHS primary care, though requesting a full panel in a single appointment may require some explanation of your concern.

Private blood testing services offer most of these markers without a GP referral if access to NHS testing is limited. The value of getting a baseline panel before beginning any supplementation or topical protocol is that it either identifies a correctable cause or rules one out, allowing a more targeted approach to whatever is driving the shedding. The article on five questions to ask before buying a hair loss product covers this diagnostic step as part of a broader framework.

Biotin (vitamin B7) is among the most heavily marketed supplements in the hair loss space. The evidence for biotin supplementation in people without biotin deficiency is essentially absent. Biotin deficiency itself is rare in people eating a varied diet; isolated biotin deficiency is principally seen in people consuming large quantities of raw egg whites over extended periods (avidin in raw egg whites binds biotin and prevents absorption), in those with rare genetic disorders affecting biotin metabolism, or in people on certain anticonvulsant medications.

Nutritional assessment is most useful as a first step, not a complete solution. If blood markers come back within normal ranges and the shedding pattern is consistent with androgenetic alopecia rather than TE, the appropriate next question is which interventions address the androgen pathway and scalp microenvironment, not which supplements to add. The article on androgenetic alopecia: what it is, what causes it, and what the options are covers that landscape in full.

If deficiencies are identified and treated, the hair cycle response takes time: several months at minimum, since the follicle must complete its current cycle before improvements at the cellular level become visible as changes in density and shedding rate. The article on how long before you see results sets realistic expectations for that timeline.

This article is provided for educational purposes and does not constitute medical advice. If you are experiencing significant hair loss or suspect a nutritional deficiency or thyroid condition, consult a qualified healthcare professional. AmpleLab products are cosmetic formulations and are not intended to diagnose, treat, cure, or prevent any condition.

AmpleLab.